hollowviper40 said:The reason I'm asking is because I'll be in a bind if I actually need more than one 20 mg tablet per day. Not to mention they're pricey—even with insurance, you're looking at nearly $10 a pop, and since the bottle only holds 14 pills, you'll run out in less than two weeks. It means constantly running back to the pharmacy counter and begging for refills. The system here is a total mess—and nothing from Mooreov's documentary "Sick" offers any comfort; it tries to suggest things are even worse in the developed West. They aren't! In places like Romania, Albania, Russia, or maybe Mexico, things are actually much worse—we just don't have a Moore to package it all up nicely and make it look cinematic. If we did, then we might finally see what's truly more sick...
So, why on earth are you sticking with the brand-name stuff? I mean, look, I get it—brand loyalty is a thing—but there are plenty of generics out there now. You could grab something like Zoloft that’s already covered by your insurance provider, which means you aren't stuck paying that massive copay like you would if you were buying Prozac. It just seems... I don't know, inefficient? Why pay the premium when the generic is right there on the formulary?
So, for about six months straight, I was on a regimen of 80 mg of Prozac daily, paired with 60 mg of Seroxat. That puts me at a total of 140 mg of SSRIs every single day. Now, if you look at standard starting doses—where 20 mg of either Prozac or Seroxat is considered an effective baseline—well, I was essentially taking seven times the usual amount. And honestly? It worked for me. So, please, spare me the judgment regarding dosage levels; everyone’s biology is different, and I trust my doctors to know exactly where the safety ceiling sits. Regarding Prozac specifically... I’ll say it again: in my experience, it has the best side-effect profile of any SSRI out there. But again, that’s just me. Medication response is intensely individual, especially when we're talking about psychotropic drugs. It's a tricky business. It's nearly impossible to engineer a truly "good" medication unless we actually pin down the underlying pathology of the condition being treated. If our theories on psychopathology are going to hold water, they need to be backed by hard, clinical facts. Until we can bridge that gap between theory and biological reality, the path toward developing truly high-quality psychiatric drugs will remain uphill.